Wird geladen...
Update on Management of Type 2 Diabetes for Cardiologists
The management of type 2 diabetes mellitus has evolved over the last several years as new antidiabetic agents continue to arrive and change the goals of diabetes care. In 2008, the U.S. Food and Drug Administration mandated that all new antidiabetic agents must demonstrate cardiovascular (CV) safety...
Gespeichert in:
| Veröffentlicht in: | Methodist Debakey Cardiovasc J |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
The Methodist Hospital Houston, Texas
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6369620/ https://ncbi.nlm.nih.gov/pubmed/30788013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14797/mdcj-14-4-273 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|